Increase the use of medical products (drugs and biologics) associated with companion diagnostics
This objective currently has developmental status, meaning it is a high-priority public health issue that has evidence-based interventions to address it, but doesn’t yet have reliable baseline data. Once baseline data are available, this objective may be considered to become a core Healthy People 2030 objective.
Topic: Health Care
Workgroup: Medical Product Safety Workgroup